Verition Fund Management’s scPharmaceuticals SCPH Stock Holding History

Verition Fund Management’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-345,572	Closed	-$1.96M	–	3895
2025 Q3	$1.96M	Buy	+345,572	New	+$1.77M	0.01%	1999
2023 Q2	–	Sell	-12,358	Closed	-$112K	–	2503
2023 Q1	$112K	Buy	+12,358	New	+$90.5K	﹤0.01%	1900

Verition Fund Management's SCPH Position: Q4 2025 in Review

Verition Fund Management sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 345,572 shares — an estimated $1.96M sold.

Verition Fund Management first reported a position in SCPH in Q1 2023 and held it in 2 quarters. The position peaked at $1.96M in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Verition Fund Management reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Verition Fund Management sold 345,572 scPharmaceuticals shares in Q4 2025, an estimated $1.96M.
Verition Fund Management first reported a position in scPharmaceuticals in Q1 2023 and held it in 2 quarters.
Verition Fund Management's scPharmaceuticals position peaked at $1.96M in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.